Brean Murray Carret & Compmany Maintains Buy, $10 Target on Xerox
Brean Murray Carret & Co reiterates its Buy rating and $10 target price on Xerox (NYSE: XRX) as the company is seen as solidly positioned for 2012.
BMC says, “We continue to believe XRX is better positioned heading into 2012 than the stock would suggest. And after our meetings [with management], we believe that Xerox could be better positioned to more greatly benefit than either we or the Street account for from 1) already signed Services deals, 2) operating leverage from this revenue, and 3)incremental opex efficiency opportunities.”
XRX closed at $7.92 per share on Tuesday.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.